Suppr超能文献

先导化合物发现中的支架选择与支架跳跃:药物化学视角

Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective.

作者信息

Zhao Hongyu

机构信息

R4MC, AP-10, Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064-6098, USA.

出版信息

Drug Discov Today. 2007 Feb;12(3-4):149-55. doi: 10.1016/j.drudis.2006.12.003. Epub 2006 Dec 14.

Abstract

Hit selection and lead generation are crucial for the success of the resource-demanding lead-optimization phase in drug discovery, and represent a major research area of medicinal chemistry today. Ligand-binding efficiency, ligand complexity, ligand-target profile complementarity and chemical tractability are important parameters in hit selection. As synthesis and assay throughput improve, a large number of analogs based on the same scaffold can be rapidly synthesized and tested. Consequently, more chemistry resources could be devoted to scaffold modifications to expand the candidate pool in lead generation. Most recently discovered druggable targets are promiscuous toward lipophilic ligands, and the hydrophobic portions of hit compounds should be preferentially modified in analog and scaffold design.

摘要

命中化合物的筛选和先导化合物的生成对于药物发现中资源需求大的先导化合物优化阶段的成功至关重要,并且是当今药物化学的一个主要研究领域。配体结合效率、配体复杂性、配体-靶点谱互补性和化学可处理性是命中化合物筛选的重要参数。随着合成和检测通量的提高,可以快速合成和测试基于同一骨架的大量类似物。因此,更多的化学资源可用于骨架修饰,以在先导化合物生成中扩大候选化合物库。最近发现的可成药靶点对亲脂性配体具有多特异性,在类似物和骨架设计中应优先修饰命中化合物的疏水部分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验